The Pennant Group (PNTG)
(Delayed Data from NSDQ)
$22.19 USD
+0.03 (0.14%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $22.17 -0.02 (-0.09%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth C Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, The Pennant Group, Inc. has a market cap of $763.83M, which represents its share price of $22.16 multiplied by its outstanding shares number of 34.47M. As a small-cap company, PNTG's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PNTG 22.19 +0.03(0.14%)
Will PNTG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PNTG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PNTG
DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates
Zacks Industry Outlook Highlights Quest Diagnostics, Encompass Health, DaVita and The Pennant
PNTG: What are Zacks experts saying now?
Zacks Private Portfolio Services
4 Stocks to Watch in a Rapidly Shifting Outpatient Home Health Space
Encompass Health to Expand Florida Presence With New 50-bed Facility
The Pennant Group (PNTG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for PNTG
What To Expect From Pennant Group Inc (PNTG) Q2 2025 Earnings
Insider Sell Alert: Brent Guerisoli Sells Shares of Pennant Group Inc (PNTG)
Pennant Announces Second Quarter 2025 Earnings Release and Call | PNTG Stock News
PNTG Stock Rating Maintained, Price Target Lowered by Truist Securities | PNTG Stock News
PNTG: Truist Adjusts Target Price Amid Q2 Healthcare Services Outlook | PNTG Stock News